BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
Moodys
Federal Trade Commission
Julphar
QuintilesIMS
Chubb
Express Scripts
Cerilliant
Deloitte

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040011

« Back to Dashboard

NDA 040011 describes METHAZOLAMIDE, which is a drug marketed by Ani Pharms Inc, Applied Anal, Mikart, and Sandoz, and is included in five NDAs. It is available from six suppliers. Additional details are available on the METHAZOLAMIDE profile page.

The generic ingredient in METHAZOLAMIDE is methazolamide. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the methazolamide profile page.
Summary for 040011
Tradename:METHAZOLAMIDE
Applicant:Applied Anal
Ingredient:methazolamide
Patents:0
Therapeutic Class:Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 040011

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG
Approval Date:Jul 17, 1997TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Jul 17, 1997TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Healthtrust
Accenture
Federal Trade Commission
Teva
Farmers Insurance
AstraZeneca
Medtronic
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot